{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:40:42Z","timestamp":1792190442627,"version":"4.4.0"},"reference-count":33,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2011.0809","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T09:20:20Z","timestamp":1525252820000},"source":"Crossref","is-referenced-by-count":11,"title":["Bronchiectasis"],"prefix":"10.3238","author":[{"given":"Jessica","family":"Rademacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Welte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2011,12,2]]},"reference":[{"key":"10.3238\/arztebl.2011.0809_ref1","doi-asserted-by":"crossref","unstructured":"Bilton D: Update on non-cystic fibrosis bronchiectasis. Curr Opin Pulm Med 2008; 14: 595\u20139.","DOI":"10.1097\/MCP.0b013e328312ed8c"},{"key":"10.3238\/arztebl.2011.0809_ref2","doi-asserted-by":"crossref","unstructured":"Twiss J, Metcalfe R, Edwards E, et al.: New Zealand national incidence of bronchiectasis \u201etoo high\u201c for a developed country. Arch Dis Child 2005; 90: 737\u201340.","DOI":"10.1136\/adc.2004.066472"},{"key":"10.3238\/arztebl.2011.0809_ref3","doi-asserted-by":"crossref","unstructured":"Fuschillo S, De Felice A, Balzano G: Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms. Eur Respir J 2008; 31: 396\u2013406.","DOI":"10.1183\/09031936.00069007"},{"key":"10.3238\/arztebl.2011.0809_ref4","doi-asserted-by":"crossref","unstructured":"Dhillon SS, Watanakunakorn C: Lady Windermere syndrome: middle lobe bronchiectasis and Mycobacterium avium complex infection due to voluntary cough suppression. Clin Infect Dis 2000; 30: 572\u20135.","DOI":"10.1086\/313726"},{"key":"10.3238\/arztebl.2011.0809_ref5","doi-asserted-by":"crossref","unstructured":"Fajac I, Viel M, Sublemontier S, et al.: Could a defective epithelial sodium channel lead to bronchiectasis. Respir Res. 2008; 9: 46.","DOI":"10.1186\/1465-9921-9-46"},{"key":"10.3238\/arztebl.2011.0809_ref6","doi-asserted-by":"crossref","unstructured":"Patel IS, Vlahos I, Wilkinson TM, et al.: Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 15; 170: 400\u20137.","DOI":"10.1164\/rccm.200305-648OC"},{"key":"10.3238\/arztebl.2011.0809_ref7","doi-asserted-by":"crossref","unstructured":"Goeminne P, Dupont L: Non-cystic fibrosis bronchiectasis: diagnosis and management in 21st century. Postgrad Med J 2010; 86: 493\u2013501.","DOI":"10.1136\/pgmj.2009.091041"},{"key":"10.3238\/arztebl.2011.0809_ref8","doi-asserted-by":"crossref","unstructured":"O\u2019Donnell AE, Barker AF, Ilowite JS, et al.: Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group. Chest 1998; 113: 1329\u201334.","DOI":"10.1378\/chest.113.5.1329"},{"key":"10.3238\/arztebl.2011.0809_ref9","doi-asserted-by":"crossref","unstructured":"Donaldson SH, Bennett WD, Zeman KL, et al.: Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med 2006; 354: 241\u201350.","DOI":"10.1056\/NEJMoa043891"},{"key":"10.3238\/arztebl.2011.0809_ref10","doi-asserted-by":"crossref","unstructured":"Kellett F, Redfern J, Niven RM: Evaluation of nebulised hypertonic saline (7%) as an adjunct to physiotherapy in patients with stable bronchiectasis. Resp Med 2005; 99: 27\u201331.","DOI":"10.1016\/j.rmed.2004.05.006"},{"key":"10.3238\/arztebl.2011.0809_ref11","doi-asserted-by":"crossref","unstructured":"Daviskas E, Anderson SD, Gomes K, et al.: Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum. Respirology 2005; 10: 46\u201356.","DOI":"10.1111\/j.1440-1843.2005.00659.x"},{"key":"10.3238\/arztebl.2011.0809_ref12","doi-asserted-by":"crossref","unstructured":"Ratjen F, Munck A, Kho P, et al.: Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE Trial. Thorax 2010; 65: 286\u201391.","DOI":"10.1136\/thx.2009.121657"},{"key":"10.3238\/arztebl.2011.0809_ref13","doi-asserted-by":"crossref","unstructured":"Drobnic ME, Su\u00f1\u00e9 P, Montoro JB, et al.: Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa. Ann Pharmacother 2005; 39: 39\u201344.","DOI":"10.1345\/aph.1E099"},{"key":"10.3238\/arztebl.2011.0809_ref14","doi-asserted-by":"crossref","unstructured":"Scheinberg P, Shore E: A pilot study of the safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis. Chest 2005; 127: 1420\u20136.","DOI":"10.1016\/S0012-3692(15)34496-2"},{"key":"10.3238\/arztebl.2011.0809_ref15","doi-asserted-by":"crossref","unstructured":"Steinfort DP, Steinfort C: Effect of long-term nebulised colistin of lung function and quality of life in patients with chronic bronchial sepsis. Intern Med J 2007; 37: 495\u20138.","DOI":"10.1111\/j.1445-5994.2007.01404.x"},{"key":"10.3238\/arztebl.2011.0809_ref16","doi-asserted-by":"crossref","unstructured":"Dhar R, Anwar GA, Bourke SC, et al.: Efficacy of nebulised colomycin in patients with non-cystic fibrosis bronchiectasis colonised with Pseudomonas aeruginosa. Thorax 2010; 65: 553.","DOI":"10.1136\/thx.2008.112284"},{"key":"10.3238\/arztebl.2011.0809_ref17","doi-asserted-by":"crossref","unstructured":"McCoy KS, Quittner AL, Oermann CM, et al.: Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis. Am J Respir Crit Care 2008; 178: 921\u20138.","DOI":"10.1164\/rccm.200712-1804OC"},{"key":"10.3238\/arztebl.2011.0809_ref18","doi-asserted-by":"crossref","unstructured":"Murray MP, Govan JR, Doherty CJ, et al.: A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 2011; 183: 491\u20139.","DOI":"10.1164\/rccm.201005-0756OC"},{"key":"10.3238\/arztebl.2011.0809_ref19","doi-asserted-by":"crossref","unstructured":"Antoniu SA, Trofor AC: Inhaled gentamicin in non-cystic fibrosis bronchiectasis: effects of long-term therapy. Expert Opin Pharmacother 2011; 12: 1191\u20134.","DOI":"10.1517\/14656566.2011.563735"},{"key":"10.3238\/arztebl.2011.0809_ref20","doi-asserted-by":"crossref","unstructured":"Tsang KW, Tan KC, Ho PL, et al.: Inhaled fluticasone in bronchiectasis: a 12 month study. Thorax. 2005; 60: 239\u201343.","DOI":"10.1136\/thx.2002.003236"},{"key":"10.3238\/arztebl.2011.0809_ref21","doi-asserted-by":"crossref","unstructured":"Shinkai M, Henke MO, Rubin BK: Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action. Pharmacol Ther 2008; 117: 393\u2013405.","DOI":"10.1016\/j.pharmthera.2007.11.001"},{"key":"10.3238\/arztebl.2011.0809_ref22","doi-asserted-by":"crossref","unstructured":"Anwar GA, Bourke SC, Afolabi G, et al.: Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis. Respir Med 2008; 102: 1494\u20136.","DOI":"10.1016\/j.rmed.2008.06.005"},{"key":"10.3238\/arztebl.2011.0809_ref23","doi-asserted-by":"crossref","unstructured":"Agarwal R: Allergic bronchopulmonary aspergillosis. Chest 2009; 135: 805\u201326.","DOI":"10.1378\/chest.08-2586"},{"key":"10.3238\/arztebl.2011.0809_ref24","doi-asserted-by":"crossref","unstructured":"Bagheri R, Haghi SZ, Fattahi Masoum SH, et al.: Surgical management of bronchiectasis: analysis of 277 patients. Thorac Cardiov Surg 2009; 58: 291\u20134.","DOI":"10.1055\/s-0030-1249941"},{"key":"10.3238\/arztebl.2011.0809_ref25","doi-asserted-by":"crossref","unstructured":"Orens JB, Estenne M, Arcasoy S, et al.: Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. International guidelines for the selection of lung transplant candidates: 2006 update\u2014a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006; 25: 745\u201355.","DOI":"10.1016\/j.healun.2006.03.011"},{"key":"10.3238\/arztebl.2011.0809_ref26","doi-asserted-by":"crossref","unstructured":"Pletz MW, McGee L, Burkhardt O, et al.: Ciprofloxacin treatment failure in a patient with resistant Streptococcus pneumoniae infection following prior ciprofloxacin therapy. Eur J Clin Microbiol Infect Dis. 2005; 24: 58\u201360.","DOI":"10.1007\/s10096-004-1254-x"},{"key":"10.3238\/arztebl.2011.0809_ref27","doi-asserted-by":"crossref","unstructured":"Rademacher J, Pletz MW, Welte T: Behandlung nicht mit zystischer Fibrose assoziierter Bronchiektasen (Non-CF-Bronchiektasen. Internist (Berl) 2010; 51: 1510\u20135.","DOI":"10.1007\/s00108-010-2716-0"},{"key":"10.3238\/arztebl.2011.0809_ref28","doi-asserted-by":"crossref","unstructured":"Bilton D, Bruinenberg P, Otulana B, et al.: Inhaled liposomal ciprofloxacin hydrochloride significantly reduces sputum pseudomonas aeruginosa density in CF and Non-CF bronchiectasis. Am J Respir Crit Care Med 179; 2009: A3214.","DOI":"10.1164\/ajrccm-conference.2009.179.1_MeetingAbstracts.A3214"},{"key":"10.3238\/arztebl.2011.0809_ref29","doi-asserted-by":"crossref","unstructured":"Wilson R, Welte T, Polverino E, et al.: Randomized, placebo-controlled, double-blind, multi-center study to evaluate the safety and efficacy of Ciprofloxacin dry powder for inhalation (Ciprofloxacin DPI) compared with placebo in patients with non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 183; 2011: A6407.","DOI":"10.1164\/ajrccm-conference.2011.183.1_MeetingAbstracts.A6407"},{"key":"10.3238\/arztebl.2011.0809_ref30","doi-asserted-by":"crossref","unstructured":"Agasthian T, Deschamps C, Trastek VF, et al.: Surgical management of bronchiectasis. Ann Thorac Surg 1996; 62: 976\u20138.","DOI":"10.1016\/0003-4975(96)00469-9"},{"key":"10.3238\/arztebl.2011.0809_ref31","doi-asserted-by":"crossref","unstructured":"Kutlay H, Cangir AK, En\u00f6n S, et al.: Surgical treatment in bronchiectasis: analysis of 166 patients. Eur J Cardiothorac Surg 2002; 21: 634\u20137.","DOI":"10.1016\/S1010-7940(02)00053-2"},{"key":"10.3238\/arztebl.2011.0809_ref32","doi-asserted-by":"crossref","unstructured":"Fujimoto T, Hillejan L, Stamatis G.: Current strategy for surgical management of bronchiectasis. Ann Thorac Surg 2001; 72: 1711\u20135.","DOI":"10.1016\/S0003-4975(01)03085-5"},{"key":"10.3238\/arztebl.2011.0809_ref33","doi-asserted-by":"crossref","unstructured":"Weiss ES, Allen JG, Meguid RA, et al.:The impact of center volume on survival in lung transplantation: an analysis of more than 10,000 cases. Ann Thorac Surg 2009; 88: 1062\u201370.","DOI":"10.1016\/j.athoracsur.2009.06.005"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2011.0809","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T15:05:51Z","timestamp":1638803151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2011.0809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,2]]},"references-count":33,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2011.0809","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,2]]}}}